
AMRN vs GYRE
$AMRN vs $GYRE head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
AMRN vs GYRE: the quick read
- ·AMRN is the larger company by market cap ($509M vs $508M).
- ·GYRE has been more active on our scanner (25 vs 24 alerts in 30 days).
- ·GYRE has the smaller float (15.4M vs 20.4M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (PHARMACEUTICAL PREPARATIONS vs Pharmaceutical Preparations), so they answer to different catalysts and a move in one says little about the other.
- ·Both stay busy on our scanner, 25 and 24 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are closely matched in size, within 0% of each other on market cap, which makes the rest of this table the interesting part.
- ·Both sit in the bottom quarter of their 52-week range, so this is a comparison of two names well off their highs.
- ·GYRE is the one in play today, trading about 2.2x its normal volume, which is what puts a name on our scanner in the first place.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing AMRN and GYRE on TheDesperateTrader.
- Is AMRN or GYRE the better stock?
- "Better" depends on your goal, and these two are not alike. AMRN is the larger company by market cap ($509M vs $508M). GYRE has been more active on our scanner (25 vs 24 alerts in 30 days). GYRE has the smaller float (15.4M vs 20.4M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between AMRN and GYRE?
- The differences that matter: they are not in the same business - AMRN is pharmaceutical preparations and GYRE is pharmaceutical preparations; they are similar in size ($509M vs $508M); they trade at very different share prices ($12.13 vs $4.60); AMRN sits at 15% of its 52-week range against 2% for GYRE; our scanner flagged AMRN 24 times in the last 30 days against 25 for GYRE. Everything above is measured from the latest completed session and SEC filings.
- Which of AMRN and GYRE is more active right now?
- Right now AMRN is at about 1.6x its normal volume and GYRE is at about 2.2x, so GYRE is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading AMRN or GYRE? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysExplore the market
Free, live market tools. No account required to look.